Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Hepatitiden

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.

Akiyama MJ, Agyemang L, Arnsten JH, Heo M, Norton BL, Schackman BR, Linas BP, Litwin AH.

BMC Infect Dis. 2018 Feb 9;18(1):74. doi: 10.1186/s12879-018-2964-5.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807730/

Zurück zum Themenbereich: Hepatitiden